Does parental drinking influence children’s drinking?


Natasha Clarke helps us understand a recent systematic review of prospective cohort studies, which explores the links between parental alcohol drinking and alcohol consumption in their offspring.

[read the full story...]

CBT plus taper may help reduce short-term benzodiazepine use


John Baker summarises a recent Cochrane systematic review of psychosocial interventions for benzodiazepine harmful use, abuse or dependence.

[read the full story...]

Should we recommend CBT for depression in people with learning disabilities?


Leen Vereenooghe summarises a systematic review of the use of CBT (cognitive behavioural therapy) to treat depression in people with learning disabilities.

[read the full story...]

Psychotherapies for depression and anxiety in dementia

The study highlighted a lack of evidence about what CMHT services work for older people.

Clarissa Giebel summarises a recent systematic review that investigates the effectiveness of various psychotherapies (CBT, interpersonal therapy, counselling) for depression and anxiety in people with dementia or mild cognitive impairment.

[read the full story...]

Suicide prevention at suicide hotspots


David Steele talks us through a systematic review and meta-analysis, which found that commonly used interventions are effective at preventing completed suicides at suicide hotspots.

[read the full story...]

Lifetime prevalence of anxiety disorders in people with bipolar disorder


Alan Underwood appraises a recent meta-analysis that finds anxiety disorders are three times more common in people with a diagnosis of bipolar disorder.

[read the full story...]

Rivastigmine for Alzheimer’s: is a small cognitive ‘improvement’ worth the risk of feeling physically unwell?

This trial suggests that antipsychotic use can be effectively reduced in nursing homes by using a review protocol.

Rosalyn Nelson presents the latest Cochrane systematic review of Rivastigmine for Alzheimer’s disease, which brings together the results of 7 industry sponsored or funded trials, and concludes that Rivastigmine may be of benefit to people with Alzheimer’s disease.

[read the full story...]

Drug-using offenders with co-occurring mental illness


Meg Fluharty summarises a recently updated Cochrane systematic review about interventions for drug-using offenders with co-occurring mental illness.

[read the full story...]

What impact are psychotropic drugs having on our physical health?


John Baker summarises the findings of a recent review of people with schizophrenia, bipolar disorder and depression. The study looks at the adverse effects on physical health of psychotropic drugs (antipsychotics, antidepressants and mood stabilisers).

[read the full story...]